March 7, 2013
Seasoned industry expert Frank Ternes joins executive Management Board read more
November 7, 2012
The family-owned business based in Laupheim has expanded its management board. As a contract manufacturing organization, Rentschler Biotechnologie GmbH performs research on, develops, and produces biologicals for its international clientele. read more
July 25, 2012
Rentschler has seen participation at this conference nearly triple since inaugural event in 2010 read more
July 17, 2012
Rentschler, one of the most qualified partners for the development and production of biopharmaceuticals worldwide, has undergone significant expansion in the past years and has transformed itself into a leading contract manufacturer of clinical trial material and for market supply of drug products ranging from low-dose cytokines to higher-dose antibodies and biosimilars read more
January 30, 2012
Rentschler Biotechnologie GmbH is pleased to announce the second Laupheimer Zelltage , a biennial industrial cell culture technology conference to be held on June 11-12, 2012 at Laupheim's historical castle, Schloss Großlaupheim. read more
January 25, 2012
Rentschler Biotechnologie GmbH, a full-service contract biomanufacturing company, is pleased to announce that the company's new manufacturing facility has won the 2012 Facility of the Year Award (FOYA) in the category Equipment Innovation. read more
January 17, 2011
Faron Pharmaceuticals Ltd. and Rentschler Biotechnologie GmbH announced today that they have signed a manufacturing and supply agreement for the Faron product FP-1201 that is also known as Traumakine®. read more
October 20, 2010
Rentschler Biotechnologie GmbH launched the first "Laupheimer Zelltage" with a symposium on "Cell Factories of the Future". read more
Rentschler Biotechnologie GmbH
Erwin-Rentschler-Str. 21
88471 Laupheim
Telefon: +49 - 7392 701-0
Telefax: +49 - 7392 701-300
E-Mail: info@rentschler.de